🔗 Share this article TikTok Influencers Driving Unofficial Trade for Unapproved Weight-Loss Drug An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings. Experimental Treatment Acquiring Popularity Via Social Media Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to message these profiles privately for source information, while also obtaining promotional offers. Thriving Commerce on Social Networks Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day British shipping. Sellers promote the drug there before directing customers to WhatsApp for transactions. Learning About Retatrutide This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic. Healthcare Professionals Voice Concerns However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering products of uncertain source. Some professionals stated the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro. Regulatory Position and Implementation Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations. Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate medicines, advertising, and customer laws, risking penalties, legal action or imprisonment. Service Reaction and Material Elimination Based on TikTok, the platform has removed violative content and banned related hashtags and search suggestions. The company said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies. Digital Trading Operations Research also found communities with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, populated with photos of weight loss, glowing reviews and detailed guides for mixing or injecting at home. Within minutes of entering one community, a vendor posted WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage. Product Details and Costs Within these groups, posts display dark colored parcels with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.” Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”. Platform Moderation and Security Actions A representative for Telegram stated it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”. Healthcare Expert Warnings “Individuals are injecting materials they cannot confirm. Although the science behind this drug is valid, these digital versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained. Her staff has already encountered patients harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.” Producer Statement A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental product not yet approved … may expose users to possibly serious health risks”.